Prospective investigation of C-11 methionine PET/CT for bone tumor

Prospective investigation of C-11 methionine PET/CT for bone tumor - Prospective investigation of C-11 methionine PET/CT for bone tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020945

Enrollment

Registered

2016-04-01

Start date

2016-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone tumor

Interventions

Preoperative examination of C-11 methionine PET/CT(C-11 methionine 3.7MBq/kg)(until March 31, 2022)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with suspected bone tumor who are to be operated.

Exclusion criteria

Exclusion criteria: Baby and toddler (under 3 years olds). Pregnant female. Nursing woman.

Design outcomes

Primary

Measure	Time frame
The correlation between C-11 methionine uptake to the bone tumor and histological findings.	—

Secondary

Measure	Time frame
The comparison between C-11 methionine PET/CT and other imaging modalities in patients with bone tumor. The assessment of the C-11 methionine uptake to internal organs with multiple-time-point PET/CT.	—

Countries

Japan

Contacts

Public ContactYoichi Otomi

Tokushima university hospital Department of Radiology

otomi.yoichi@tokushima-u.ac.jp088-633-7173

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026